Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/01/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 12/20/16
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 09/20/19
End: 01/31/23
Due: 01/31/24
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 07/31/16
Due: 07/31/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility | NCT06481696 | Andros Day Surgery Clinic | user2@example.com | None | 2024-06-01 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles | NCT03181685 | Andros Day Surgery Clinic | user2@example.com | None | 2016-12-20 | 2019-12-31 | 2020-12-31 | - | - | 2025-07-14 |
| Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response | NCT04168892 | Andros Day Surgery Clinic | user2@example.com | None | 2019-09-20 | 2023-01-31 | 2024-01-31 | - | - | 2025-07-14 |
| Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles | NCT01816789 | Andros Day Surgery Clinic | user2@example.com | None | 2013-03-31 | 2016-07-31 | 2017-07-31 | - | - | 2025-07-14 |